REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Peroxidase AffiniPure goat anti-human IgG (H + L) antibody | Jackson ImmunoResearch | Cat# 109-035-003 RRID: AB_2337577 |
Bacterial and virus strains | ||
VSV-G pseudotyped ΔG-luciferase | Kerafast | Cat# EH1020-PM |
Biological samples | ||
“4-dose monovalent” sera | This paper | N/A |
“3-dose monovalent + bivalent” sera | This paper | N/A |
“BA.5 breakthrough” sera | This paper | N/A |
“BQ breakthrough” sera | This paper | N/A |
Chemicals, peptides, and recombinant proteins | ||
Polyethylenimine (PEI) | Polysciences Inc. | Cat# 23966-100 |
SARS-CoV-2 D614G S2P | Wang et al.13 | N/A |
SARS-CoV-2 BA.5 S2P | Wang et al.13 | N/A |
SARS-CoV-2 BQ.1.1 S2P | Wang et al.15 | N/A |
Critical commercial assays | ||
Luciferase Assay System | Promega | Cat# E4550 |
QuikChange Lightning Site-Directed Mutagenesis Kit | Agilent | Cat# 210518 |
TMB substrate | Sigma-Aldrich | Cat# T0440 |
Experimental models: Cell lines | ||
HEK293T | ATCC | Cat# CRL-3216; RRID: CVCL_0063 |
Vero-E6 | ATCC | Cat# CRL-1586; RRID: CVCL_0574 |
Recombinant DNA | ||
pCMV3-D614G | Wang et al.13 | N/A |
pCMV3-BA.2 | Wang et al.13 | N/A |
pCMV3-BA.4/5 | Wang et al.13 | N/A |
pCMV3-BQ.1.1 | Wang et al.15 | N/A |
pCMV3-CH.1.1 | Wang et al.16 | N/A |
pCMV3-XBB.1.5 | This paper | N/A |
pCMV3-XBB.1.16 | This paper | N/A |
pCMV3-XBB.1.5-E180V | This paper | N/A |
pCMV3-XBB.1.5-K478R | This paper | N/A |
Software and algorithms | ||
GraphPad Prism 9 | GraphPad Software Inc | https://www.graphpad.com/scientific-software/prism/ |